HP
AMAM

HealthInvest Partners’s Ambrx Biopharma Inc AMAM Stock Holding History

HealthInvest Partners’s Portfolio AMAM Stock Details AMAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-57,847
Closed -$824K – 50
2023
Q4 		$824K Buy
+57,847
New +$657K 0.64% 32

HealthInvest Partners's AMAM Position: Q1 2024 in Review

HealthInvest Partners sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 57,847 shares — an estimated $824K sold.

HealthInvest Partners first reported a position in AMAM in Q4 2023 and held it in 1 quarter. The position peaked at $824K in Q4 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

  • HealthInvest Partners reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
  • HealthInvest Partners sold 57,847 Ambrx Biopharma Inc shares in Q1 2024, an estimated $824K.
  • HealthInvest Partners first reported a position in Ambrx Biopharma Inc in Q4 2023 and held it in 1 quarter.
  • HealthInvest Partners's Ambrx Biopharma Inc position peaked at $824K in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on HealthInvest Partners's 13F filing for Q1 2024, filed 25 Apr 2024.